Skip to content

Smell and Taste Dysfunction in Children with Cancer

’Smell and Taste (Dys)function in Children with Cancer - a Feasibility Study’

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON25750
Enrollment
60
Registered
2019-02-18
Start date
2019-03-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Childhood cancer patients

Interventions

None listed

Sponsors

Princess Máxima Center
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Inclusion criteria patients: - Children, 6-17 years old - Currently undergoing chemotherapy Inclusion criteria controls (siblings): - Children, 6-17 years old

Exclusion criteria

Exclusion criteria: Exclusion criteria patients: - Children with isolated congenital anosmia (ICA; a complete loss of smell) - Children = 5 years - Children and parents that do not understand the Dutch language - Children with a self-reported allergy to quinine - Children with severe oral mucositis (treatment-induced ulceration of the mucosa, blis-tered tongue, and absence of saliva) Exclusion criteria controls: - Children with isolated congenital anosmia (ICA; a complete loss of smell) - Children = 5 years - Children and parents that do not understand the Dutch language - Children with a self-reported allergy to quinine

Design outcomes

Primary

MeasureTime frame
The main study parameter is feasibility of the study. Therefore we will test whether the lower age range is suitable to be tested. If not, for our next studies we will increase the lower age limit. The number of patients fully completing the study is the main endpoint.

Secondary

MeasureTime frame
- Smell function - Taste function - Subjective smell and taste function (questionnaire) - Papillae density - Eating behaviour

Contacts

Public ContactMirjam van den Brink

Prinses Maxima Center

M.vandenBrink-9@prinsesmaximacentrum.nl088 97 25193

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)